Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023772 · ClinicalTrials.gov registry record · NA
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
A NA study of Neoplasm Metastasis and Spinal Cord Diseases, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05023772: Recruiting NA study of Neoplasm Metastasis and Spinal Cord Diseases, sponsored by Henry Ford Health System.
NCT05023772 is a NA study of Neoplasm Metastasis and Spinal Cord Diseases that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 60 participants, below the 414-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05023772, a NA study of Neoplasm Metastasis and Spinal Cord Diseases, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.
Primary Outcome
Kaplan-Meier estimates will be used.
Conditions Studied
Interventions
- RADIATION Stereotactic Radiosurgery
- PROCEDURE Stereotactic Laser Ablation
- DIAGNOSTIC_TEST MRI guided laser ablation
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-09-02 |
| Est. Completion | 2026-12-20 |
| Phase | NA |
What NCT05023772 shows while recruiting
NCT05023772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 414-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (86% lower).
The record links to 5 conditions, with Neoplasm Metastasis appearing as the primary indexed condition, and to 3 interventions - of which Stereotactic Radiosurgery is the first listed.
NCT05023772 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05023772 about?
NCT05023772 is a clinical study titled "Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases". The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function,...
What is the current status of trial NCT05023772?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-09-02. Estimated completion is 2026-12-20.
What conditions does trial NCT05023772 study?
This clinical trial studies the following conditions: Neoplasm Metastasis, Spinal Cord Diseases, Spine Metastases, Spinal Cord Compression, Spinal Cord Tumor.
What interventions are being tested in trial NCT05023772?
The interventions under investigation include: Stereotactic Radiosurgery (RADIATION), Stereotactic Laser Ablation (PROCEDURE), MRI guided laser ablation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05023772?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05023772 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm Metastasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05023772's enrollment target sits among peer trials
60 28th of 41 higher than 13 of 41 other Neoplasm Metastasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasm Metastasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
RECRUITING · Phase 1
-
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
RECRUITING · Phase 1
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI